skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Female remover assunto: Oncology remover Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo

SATO, K ; YUASA, T ; NOGAWA, M ; KIMURA, S ; SEGAWA, H ; YOKOTA, A ; MAEKAWA, T

British journal of cancer, 2006-11, Vol.95 (10), p.1354-1361 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer

TAKIGAWA, Nagio ; SEGAWA, Yoshihiko ; UEOKA, Hiroshi ; KIURA, Katsuyuki ; TABATA, Masahiro ; SHIBAYAMA, Takuo ; TAKATA, Ichiro ; MIYAMOTO, Hiroaki ; EGUCHI, Kenji ; HARADA, Mine

Cancer chemotherapy and pharmacology, 2000, Vol.46 (4), p.272-278 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível

Citações Citado por
3
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study

UEOKA, H ; TABATA, M ; KIURA, K ; SHIBAYAMA, T ; GEMBA, K ; SEGAWA, Y ; CHIKAMORI, K ; YONEI, T ; HIRAKI, S ; HARADA, M

British journal of cancer, 1999-02, Vol.79 (5-6), p.984-990 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy

Segawa, Y. ; Aogi, K. ; Inoue, K. ; Sano, M. ; Sekine, I. ; Tokuda, Y. ; Isobe, H. ; Ogura, T. ; Tsuboi, M. ; Atagi, S.

Annals of oncology, 2009-11, Vol.20 (11), p.1874-1880 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of peroxisome proliferator‐activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists

Yoshimura, Rikio ; Matsuyama, Masahide ; Segawa, Yoshihiro ; Hase, Taro ; Mitsuhashi, Makoto ; Tsuchida, Kennji ; Wada, Seiji ; Kawahito, Yutaka ; Sano, Hajime ; Nakatani, Tatsuya

International journal of cancer, 2003-05, Vol.104 (5), p.597-602 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
6
Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007

SEGAWA, Yoshihiko ; KIURA, Katsuyuki ; DEOKA, Hiroshi ; TAKEMOTO, Mitsuhiro ; KANAZAWA, Susumu ; TAKATA, Ichiro ; NOGAMI, Naoyuki ; HOTTA, Katsuyuki ; HIRAKI, Akio ; TABATA, Masahiro ; MATSUO, Keitaro ; TANIMOTO, Mitsune ; TAKIGAWA, Nagio ; KAMEI, Haruhito ; HARITA, Shingo ; HIRAKI, Shunkichi ; WATANABE, Yoichi ; SUGIMOTO, Keisuke ; SHIBAYAMA, Takuo ; YONEI, Toshiro

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3299-3306 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

KAWAHARA, M ; FURUSE, K ; SEGAWA, Y ; YOSHIMORI, K ; MATSUI, K ; KUDOH, S ; HASEGAWA, K ; NIITANI, H

British journal of cancer, 2001-09, Vol.85 (7), p.939-943 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer

TAKIGAWA, N ; KIURA, K ; TABATA, M ; SHINKAI, T ; HIRAKI, S ; TAKEMOTO, M ; KANAZAWA, S ; MATSUO, K ; TANIMOTO, M ; SEGAWA, Y ; WATANABE, Y ; KAMEI, H ; MORITAKA, T ; SHIBAYAMA, T ; UEOKA, H ; GEMBA, K ; YONEI, T

British journal of cancer, 2006-11, Vol.95 (9), p.1142-1144 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung
Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung

SEKI, Nobuhiko ; TAKASU, Tasaburo ; MANDAI, Koichi ; NAKATA, Masao ; SAEKI, Hideyuki ; HEIKE, Yuji ; TAKATA, Ichiro ; SEGAWA, Yoshihiko ; HANAFUSA, Toshiaki ; EGUCHI, Kenji

Clinical cancer research, 2002-10, Vol.8 (10), p.3046-3053 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Maemondo, M. ; Masuda, N. ; Sekine, I. ; Kubota, K. ; Segawa, Y. ; Shibuya, M. ; Imamura, F. ; Katakami, N. ; Hida, T. ; Takeo, S.

Annals of oncology, 2009-11, Vol.20 (11), p.1860-1866 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (270)

Data de Publicação 

De até
Refinar
  1. Antes de1996  (5)
  2. 1996Até1999  (23)
  3. 2000Até2003  (49)
  4. 2004Até2008  (86)
  5. Após 2008  (114)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.